Humoral immunity of BBIBP-CorV (Sinopharm) in kidney transplant recipients: Is it time to revise vaccination strategies.

Mohsen Nafar Saghar Chehrazi Nooshin DaliliAhmad FirouzanFatemeh Pour-Reza-Gholi Fariba Samadian Shiva Samavat

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2022)

BBIBP-CorV vaccine can be used safely in kidney transplant recipients, although impaired cellular and humoral immunity necessitate adjustments in vaccination strategies, like higher (8-μg doses), fourth booster dose, or boost with different platform vaccine.

Keyphrases

immune response